These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8276876)

  • 1. Antigen recognition by an antibody light chain.
    Sun M; Li L; Gao QS; Paul S
    J Biol Chem; 1994 Jan; 269(1):734-8. PubMed ID: 8276876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular cloning of a proteolytic antibody light chain.
    Gao QS; Sun M; Tyutyulkova S; Webster D; Rees A; Tramontano A; Massey RJ; Paul S
    J Biol Chem; 1994 Dec; 269(51):32389-93. PubMed ID: 7798238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic activity of an antibody light chain.
    Sun M; Gao QS; Li L; Paul S
    J Immunol; 1994 Dec; 153(11):5121-6. PubMed ID: 7963569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient vasoactive intestinal polypeptide hydrolyzing autoantibody light chains selected by phage display.
    Tyutyulkova S; Gao QS; Thompson A; Rennard S; Paul S
    Biochim Biophys Acta; 1996 Aug; 1316(3):217-23. PubMed ID: 8781541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide hydrolysis by antibody light chains.
    Mei S; Mody B; Eklund SH; Paul S
    J Biol Chem; 1991 Aug; 266(24):15571-4. PubMed ID: 1908455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The critical role of arginine residues in the binding of human monoclonal antibodies to cardiolipin.
    Giles I; Lambrianides N; Latchman D; Chen P; Chukwuocha R; Isenberg D; Rahman A
    Arthritis Res Ther; 2005; 7(1):R47-56. PubMed ID: 15642142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiotypic analysis of monoclonal anti-fluorescyl antibodies: localization and characterization of idiotypic determinants.
    Kranz DM; Voss EW
    Mol Immunol; 1983 Dec; 20(12):1301-12. PubMed ID: 6197634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-peptide reagent identifies a primary-structure-dependent, cross-reactive idiotype expressed on heavy and light chains from a murine monoclonal anti-CD4.
    Attanasio R; Kanda P; Stunz GW; Buck DW; Kennedy RC
    Mol Immunol; 1993 Jan; 30(1):9-17. PubMed ID: 8417378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen binding of an ovomucoid-specific antibody is affected by a carbohydrate chain located on the light chain variable region.
    Fujimura Y; Tachibana H; Eto N; Yamada K
    Biosci Biotechnol Biochem; 2000 Nov; 64(11):2298-305. PubMed ID: 11193395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides, Ab1 and Ab2 antibodies II. Light versus heavy chain: An idiotype-anti-idiotype case study.
    López-Requena A; Rodríguez M; de Acosta CM; Moreno E; Puchades Y; González M; Talavera A; Valle A; Hernández T; Vázquez AM; Pérez R
    Mol Immunol; 2007 Feb; 44(5):1015-28. PubMed ID: 16620986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the structural correlates for antibody polyreactivity by multiple reassortments of chimeric human immunoglobulin heavy and light chain V segments.
    Ichiyoshi Y; Casali P
    J Exp Med; 1994 Sep; 180(3):885-95. PubMed ID: 8064239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An analysis of idiotype expression in a high-affinity, somatically mutated variant of a germline-encoded anti-p-azobenzenearsonate antibody.
    Nisonoff A; Oliveira TM; Sharon J
    Int Immunol; 1993 Jan; 5(1):1-9. PubMed ID: 8443119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low level formation of potent catalytic IgG fragments mediated by disulfide bond instability.
    Li L; Sun M; Gao QS; Paul S
    Mol Immunol; 1996; 33(7-8):593-600. PubMed ID: 8760270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment.
    Paul S; Li L; Kalaga R; Wilkins-Stevens P; Stevens FJ; Solomon A
    J Biol Chem; 1995 Jun; 270(25):15257-61. PubMed ID: 7797511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regeneration of antidigoxin binding activity in an antibody by changes surrounding the original binding defect.
    Hudson NW; Albrecht M; Randhawa ZI; Steinrauf LK; Hamilton JA
    Mol Immunol; 1993 May; 30(7):685-93. PubMed ID: 8487784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling and site-directed mutagenesis of an anti-phosphotyrosine antibody predicts the combining site and allows the detection of higher affinity interactions.
    Ruff-Jamison S; Glenney JR
    Protein Eng; 1993 Aug; 6(6):661-8. PubMed ID: 7694275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiolipin binding a light chain from lupus-prone mice.
    Pereira B; Benedict CR; Le A; Shapiro SS; Thiagarajan P
    Biochemistry; 1998 Feb; 37(5):1430-7. PubMed ID: 9477972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.